We welcome contributions from readers in the following categories:
Oncology Nurse Advisor Forum: Answers to clinical questions and advice for clinical problems. Readers may submit questions and requests for advice that are 50 to 100 words long. The author should include full name and degrees, name of institution or practice, and city and state.
To submit a question, click HERE.
Feature article: Oncology Nurse Advisor welcomes feature articles on the administration and handling of chemotherapy drugs, side-effect management, communication with patients and families, what's new in the treatment of specific cancers or cancer-related conditions, and other topics of interest to oncology nurses. Manuscripts should be 1,500 to 3,000 words long and should include a brief reference list.
Reflections: These are brief, reflective essays or narratives recounting a meaningful experience with a patient. Manuscripts should be 500 to 1500 words long.
Case Study: This department focuses on clinical cases of interest to oncology nurses. Manuscripts should be written in the standard case-followed-by-discussion format and should be 1500 to 2000 words long. A brief reference list may accompany the discussion section. Please include a list of 3 to 5 take-home points (teaching points) for the reader.
Click here for a template to follow when creating your article.
Ask a Pharmacist: In this department, our oncology pharmacist answers readers' drug-related questions. Questions should be 50 to 100 words. The author should include full name and degrees, name of institution or practice, and city and state.
Manuscript preparation requirements:
1. Use a plain, readable typeface, such as 12-point Arial or Times New Roman. Do not use decorative or italic fonts, place borders or section breaks in the manuscript, or use other types of formatting that may be difficult to remove or may otherwise make editing difficult.
2. Include a title page. On the title page, list all authors in the order they should appear on the published article. Identify the corresponding author if there is more than one author. For each author, include full name with degrees, followed by work affiliations with city and state (as they should appear in the bio box on the published article) and contact information (mailing address, phone and fax numbers, e-mail address).
3. Create all text in Microsoft Word so that it can be edited. PowerPoint may be used if you are providing a graphic illustration, such as a bar graph, that we can recreate; in this instance, supply the numerical data used to create the graphic.
4. Expand all acronyms on first mention. Example: white blood cells (WBCs).
5. Provide units of measure for all laboratory values or other clinical measures that are expressed in number form. Example: when giving a blood glucose level, please write 90 mg/dL, not 90.
6. Refer to drugs using their generic names. If you are recounting a case and the patient took a specific brand name drug, please provide the brand name in parentheses.
7. Cite every table and figure at an appropriate place in the text. Example: "A radiograph of this fracture is shown in Figure 1." Number tables and figures sequentially in the order in which they are to appear.
8. Place figures, tables, algorithms, and other accessory material at the end of the file (or in a separate file), and number them consecutively in order of their appearance in the text. Do not embed this material in the body of the text.
9. Submit photographs and imaging studies as high-resolution digital image files. The format may be jpeg, tiff, or eps. As a general rule, high-resolution equals a minimum of 300 dpi, which typically translates into a file size of 400KB or larger.
10. In your submission email, please specify the type of article you are submitting (feature article, Case of the Month, etc). Please also (1) affirm that the manuscript is original, written by you (and your co-authors, if any), and not ghost-written by anyone not named as an author; (2) note whether a pharmaceutical company or medical education company was involved with or paid for the development of the article; and (3) affirm that the manuscript is not being considered for publication elsewhere.
Note that authors should not submit an article for publication in any other journal while it is being considered for publication in Oncology Nurse Advisor and should not submit to ONA a manuscript that is currently under consideration elsewhere. Submissions should be made to only one publication at a time.
E-mail the manuscript files to firstname.lastname@example.org. Electronic submission of an editable file is required. We cannot consider hard copy manuscripts or pdf files.
Authors receive a small honorarium for published articles, payable in the month that the article is published.
If you have questions or want to discuss the feasibility of your topic before submitting, please e-mail email@example.com.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
- RANKL Inhibition May Represent Promising Breast Cancer Prevention Strategy
- Bi-allelic Inactivation Common in BRCA1 and BRCA Breast Cancers
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|